Genus (LON:GNS)‘s stock had its “buy” rating reaffirmed by stock analysts at Peel Hunt in a research report issued on Thursday, LSE.Co.UK reports. They currently have a GBX 3,200 ($41.81) price objective on the stock. Peel Hunt’s target price points to a potential upside of 23.74% from the company’s previous close.

GNS has been the topic of a number of other reports. Stifel Nicolaus started coverage on shares of Genus in a research note on Wednesday, May 29th. They issued a “hold” rating and a GBX 2,685 ($35.08) target price on the stock. Peel Hunt reissued a “buy” rating and issued a GBX 3,200 ($41.81) target price on shares of Genus in a research note on Thursday. Finally, Liberum Capital reissued a “buy” rating on shares of Genus in a research note on Friday, May 17th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of GBX 2,819.17 ($36.84).

GNS traded down GBX 12 ($0.16) during trading on Thursday, reaching GBX 2,586 ($33.79). The company’s stock had a trading volume of 31,115 shares, compared to its average volume of 78,154. The company has a quick ratio of 1.32, a current ratio of 2.08 and a debt-to-equity ratio of 22.58. The firm has a fifty day simple moving average of GBX 2,605.64 and a two-hundred day simple moving average of GBX 2,470.40. Genus has a 1 year low of GBX 2,090 ($27.31) and a 1 year high of GBX 2,950 ($38.55). The company has a market cap of $1.68 billion and a price-to-earnings ratio of -239.44.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Article: Economic Bubble

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.